Latest News and Press Releases
Want to stay updated on the latest news?
-
Federal Court Finds Abacus Plausibly Alleged a “scheme to destroy Abacus” and Denies Coventry’s Motion to Dismiss – Depositions, including Chairman Buerger and Coventry Executive Team to Move Ahead ...
-
WEST PALM BEACH, Florida, June 26, 2026 (GLOBE NEWSWIRE) -- Quantum Cyber N.V. (Nasdaq: QUCY) (“Quantum Cyber” or the “Company”), a Nasdaq-listed autonomous defense technology company assembling an...
-
IP Strategy Highlights Story Foundation's Transition to The DATA Foundation and Launch of DATA Network
-
ALAMEDA, Calif., June 26, 2026 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (NASDAQ: VANI) (“Vivani” or the “Company”), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting...
-
Memorandum of Understanding signed today establishes a framework to explore mechanisms for investors in Ukraine to access Kyivstar’s existing Nasdaq-listed shares Dubai, Kyiv, and New York, June 26,...
-
HOUSTON and LONDON, June 26, 2026 (GLOBE NEWSWIRE) -- Baker Hughes (NASDAQ: BKR) will announce the results of the second quarter ending June 30, 2026, via press release at 5 p.m. Eastern Time (4...
-
SAN FRANCISCO and VANCOUVER, British Columbia, June 26, 2026 (GLOBE NEWSWIRE) -- Jade Biosciences, Inc. (the “Company” or “Jade”) (Nasdaq: JBIO), a clinical-stage biotechnology company focused on...
-
Balchem Corporation to Participate in the CJS Securities 26th Annual New Ideas Summer Conference on July 9, 2026
-
WAYNE, Pa., June 26, 2026 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company fully dedicated to developing therapeutics targeting the IL-1β pathway...
-
NEW YORK, June 26, 2026 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today...